Astro-Med, Inc., d/b/a AstroNova (NASDAQ: ALOT) designs, manufactures, distributes and services a broad range of products that acquire, store, analyze and present data in multiple formats. The company’s Product Identification segment offers a variety of hardware and software products and … Continue reading →

PeerLogix (OTC: LOGX) is a data aggregation company using proprietary software to enable the tracking and cataloguing of Torrent files and Torrent networks to determine consumer trends and preferences based upon media consumption. PeerLogix’s patent pending platform collects Torrent data, … Continue reading →

As The Digital Engagement Company™, Bridgeline Digital’s (NASDAQ: BLIN) strategy is to help customers maximize the performance of their full digital experience – from websites and intranets to online stores and campaigns. The company’s iAPPS platform deeply integrates web content … Continue reading →

Soligenix (OTC: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company has two active business segments. The BioTherapeutics segment is developing a photo-dynamic therapy … Continue reading →

PURE Bioscience (OTC: PURE) is commercializing its patented antimicrobial products (FDA-approved PURE Control® and EPA registered PURE® Hard Surface) providing less toxic and more effective food safety solutions for food processors/manufacturers, retailers and restaurants. Test data demonstrate PURE’s products’ superior … Continue reading →

Integrity Applications (OTC: IGAP) is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes. Integrity Applications operates primarily through its wholly owned Israeli subsidiary, A.D. Integrity Applications, … Continue reading →

Relmada Therapeutics (OTC: RLMD), a clinical-stage biopharmaceutical company, develops novel versions of proven drug products combined with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. The company has four lead products … Continue reading →

Antibe Therapeutics (OTC: ATBPF) develops medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer non-steroidal … Continue reading →

Q BioMed (OTC: QBIO) is a biomedical acceleration and development company that is focused on acquiring undervalued biomedical assets. Q BioMed is dedicated to providing these target assets, strategic resources, developmental support, and expansion capital to accelerate development and, ultimately, … Continue reading →

General Employment Enterprises, Inc. (NYSE: JOB) provides specialized staffing solutions, operating in two industry segments: providing professional staffing services and solutions in the information technology, engineering, finance and accounting specialties and light industrial staffing services through the names of General … Continue reading →